- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Human papillomavirus 9-valent vaccine (recombinant, adsorbed) is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- J07BM03 Human papillomavirus 9-valent vaccine (recombinant, adsorbed) · HPV vaccine
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Biologic
- Yes
All presentations
No presentations of Human papillomavirus 9-valent vaccine (recombinant, adsorbed) are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Human papillomavirus 9-valent vaccine (recombinant, adsorbed) available for export from India?
No presentation of Human papillomavirus 9-valent vaccine (recombinant, adsorbed) is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Human papillomavirus 9-valent vaccine (recombinant, adsorbed) authorised in the European Union?
Yes. Human papillomavirus 9-valent vaccine (recombinant, adsorbed) has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Human papillomavirus 9-valent vaccine (recombinant, adsorbed) need cold chain shipping?
No listed presentation of Human papillomavirus 9-valent vaccine (recombinant, adsorbed) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Human papillomavirus 9-valent vaccine (recombinant, adsorbed) in?
Human papillomavirus 9-valent vaccine (recombinant, adsorbed) is classified under ATC code J07BM03 (Human papillomavirus 9-valent vaccine (recombinant, adsorbed)).
References
- Gardasil 9: European public assessment report (EPAR). European Medicines Agency. Retrieved 8 September 2026
Request Human papillomavirus 9-valent vaccine (recombinant, adsorbed) for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.